Recently, genetic counselling and genetic testing of BRCA1 and BRCA2 for the presence of germline inactivating mutations have been increasingly offered to identify individuals at elevated risk of breast and ovarian cancer in Korea. Here, BRCA1 is linked to ovarian carcinoma.